0,0721 <%= Resources.Global.txtUp %>
Opdateret 15:13:17
Ændring % 0,14% Stigning i aktiekurs
Ændring 0,0001 Stigning i aktiekurs
Volume 136.161
Høj 0,0751
Lav 0,0721
Åben 0,0740
ISIN FR0010397232
Seneste luk 0,0720
# af aktier 54,19M
Markedsværdi 3,91M EUR
I dag

Novacyt
Markedet er åbent (indtil 17:30) - Forsinket 15 min
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  0,07 -6,4% Fald i aktiekurs -2,6% Fald i aktiekurs -37,8% Fald i aktiekurs -70,7% Fald i aktiekurs -85,9% Fald i aktiekurs
Powered by TradingView

Firmaprofil

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology testing. It offers NovaPrep, a liquid-based cytology solution that is utilized in the diagnosis of cervical cancer; and clinical laboratory testing services to clinicians, healthcare providers, and patients. It also develops, manufactures, and distributes diagnostic products for clinical and food laboratories; and manufactures and markets vitro diagnostic tests, as well as diagnostic reagents, test kits, and blood grouping reagents. The company operates in three segments comprising Cytology, Diagnostics and Molecular products.

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. september 2019 15:32:02
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190829.2 - EUROWEB4 - 2019-09-18 15:32:02 - 2019-09-18 15:32:02 - 1 - Website: OKAY